Finance

Beta
Lists
5FA:FRA
Nipro Corp
€9.15
+1.67%
(+0.15) 1D
Jun 3, 5:15:02 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 5FA...
Open
€9.15
High
€9.15
Low
€9.15
Mkt. cap
297.31B
Avg. vol.
2.00
Volume
0.00
52-wk high
€9.20
52-wk low
€7.30
No. of employees
39K
Open
€9.15
High
€9.15
Low
€9.15
Mkt. cap
297.31B
Avg. vol.
2.00
Volume
0.00
52-wk high
€9.20
52-wk low
€7.30
No. of employees
39K
News stories
From sources across the web
Profile
Nipro Corporation is a Japanese medical equipment manufacturing company. Founded in 1954, the company is headquartered in Osaka and is listed on the Tokyo Stock Exchange and the Osaka Securities Exchange. As of 2013 the company has 58 subsidiaries in Japan, Asia, North and South America and Europe. Wikipedia
About Nipro Corp
CEO-
Employees39.2K
FoundedJul 8, 1954
Headquarters-
SectorMedical device
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
159.22B
158.16B
169.92B
173.23B
Cost of goods sold
109.06B
108.20B
118.74B
116.25B
Cost of revenue
109.06B
108.20B
118.74B
116.25B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
42.94B
41.84B
39.77B
46.10B
Operating expense
42.12B
42.67B
39.75B
46.12B
Total operating expenses
151.18B
150.86B
158.49B
162.38B
Operating income
8.04B
7.30B
11.43B
10.86B
Other non operating income
-738.00M
92.00M
-1.40B
-1.00B
EBT including unusual items
7.62B
4.83B
15.80B
1.24B
EBT excluding unusual items
3.50B
4.74B
11.99B
-502.00M
Income tax expense
3.81B
2.01B
4.11B
3.81B
Effective tax rate
49.99%
41.54%
26.02%
306.84%
Other operating expenses
-827.00M
827.00M
-
-
Net income
3.27B
2.63B
10.78B
-3.18B
Net profit margin
2.05%
1.67%
6.34%
-1.84%
Earnings per share
-
-
-
-
Interest and investment income
560.00M
684.00M
544.00M
810.00M
Interest expense
-2.06B
-2.41B
-2.46B
-2.83B
Net interest expenses
-1.50B
-1.73B
-1.91B
-2.02B
Depreciation and amortization charges
-
-
-
-
EBITDA
-
22.91B
-
26.79B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more